Mehmet Emin ARAYİCİ, Femin YALÇIN, Hülya ELLİDOKUZ

Kanser Kaydının Önemi ve Kanser Kontrolündeki Yeri

Tanımlanmış topluluklardaki tüm kanser olguları hakkında bilgi kaydetme fikri, yirminci yüz yılın ilk yarısına dayanmaktadır. Son 20 yılda kayıtların rolü, kanser kontrol faaliyetlerinin planlanması, değerlendirilmesi ve epidemiyolojisi ile kanser hastalarının bireysel bakımını kapsayacak şekilde daha da genişlemiştir. Kanser kontrolü, önleme, erken tanı, tedavi ve palyatif bakımda kanıta dayalı müdahalelerin sistematik olarak uygulanması yoluyla kanser insidansını, morbiditesini ve mortalitesini azaltmayı ve kanser hastalarının yaşam kalitesini iyileştirmeyi amaçlamaktadır. Bu noktada, ulusal ve uluslararası bir kanser kontrol programı çerçevesinde, toplum tabanlı bir kanser kayıt merkezi etrafında temellendirilen bir kanser sürveyans programı önemli bir role sahiptir. Bu nedenle hastane tabanlı kanser kayıt sistemleri, tümör patolojisi tabanlı kanser kayıt sistemleri ve buradaki bilgilerin toplanmasıyla oluşturulan toplum tabanlı kanser kayıt sistemleri, kanser kontrol planlarının oluşturulmasında ve başarılarının izlenmesinde önemli bir rol oynar.

Importance of Cancer Registration and its Place in Cancer Control

The idea of recording information about all cancer cases in identified populations dates back to the first half of the twentieth century. In the last 20 years, the role of registries has expanded further to encompass the planning, evaluation, and epidemiology of cancer control activities and the individual care of cancer patients. Cancer control aims to reduce cancer incidence, morbidity and mortality through the systematic implementation of evidence-based interventions in prevention, early diagnosis, treatment and palliative care and to improve the quality of life of cancer patients. At this point, a cancer surveillance program based around a community-based cancer registry center within the framework of a national and international cancer control program has a very important role. For this reason, hospital-based cancer registry systems, tumor pathology-based cancer registry systems, and community-based cancer registry systems created by collecting the information there play an important role in the creation of cancer control plans and monitoring their success.

PDF

___

1. Parkin DM. The evolution of the population-based cancer registry. Nature Publishing Group 2006; 603:612-6.
2. Kanser İstatistikleri. Türk Kanser Araştırma ve Savaş Kurumu Derneği. Erişim tarihi: 16.12.2020, erişim adresi: http://www.turkkanser.org/uploads/ dosyalar/istatistikler/dunya-kanser-istatistikleri. pdf
3. Jensen OM. (Ed.). Cancer Registration: Principles and Methods. Vol. 95. IARC;1991.
4. World Health Organization. IARC History. Erişim tarihi: 22.01.2021, erişim adresi: https://www. iarc.who.int/iarc-history/
5. International Association of Cancer Registries (IACR). History and aims of the association. Erişim tarihi: 12.02.2021, erişim adresi: http://www.iacr.com.fr/index.php?option=com_ content&view=article&id=89&Itemid=439
6. World Health Organization. IARC Publications: Cancer Incidence in Five Continents Volume XI. Erişim tarihi: 18.01.2021, erişim adresi: https:// publications.iarc.fr/597
7. Tuncer M. Ulusal Kanser Programı 2009-2015. TC Sağlık Bakanlığı Kanserle Savaş Dairesi Başkanlığı: Yayın No 760; 2009.
8. T.C. Cumhurbaşkanlığı Resmi Gazete. Erişim tarihi: 22.01.2021, erişim adresi: https://www.resmigazete.gov.tr/eskiler/ 2015/06/20150603-9.htm
9. T.C. Sağlık Bakanlığı. 2013-2018 Ulusal Kanser Kontrol Planı. Erişim Tarihi: 20.01.2021, erişim adresi: https://www.iccp-portal.org/system/files/ plans/Ulusal_Kanser_Kontrol_Plani_2013_2018. pdf
10. Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A, Wang SA, Parkin, DM. Planning and Developing Population-Based Cancer Registration in Low- and Middle-Income Settings. International Agency for Research on Cancer. France: IARC Technical Publication No. 43; 2015.
11. CanReg5. International Association of Cancer Registries (IACR). Erişim tarihi 14.12.2020, erişim adresi: http://www.iacr.com.fr/index.php?option= com_content&view=article&id=9:canreg5&- catid=68&Itemid=445
12. Surveillance, Epidemiology, and, End Results (SEER). Program Populations (1969-2018). Erişim tarihi: 12.02.2021, erişim adresi: http://www. seer.cancer.gov/popdata
13. White MC, Babcock F, Hayes NS, Mariotto AB, Wong FL, Kohler BA, Weir HK. The history and use of cancer registry data by public health cancer control programs in the United States, Cancer 2017; 4969:4976-123.
14. Miller KD, Fidler‐Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults. A Cancer Journal for Clinicians 2020; 70(6):443-459.
15. World Health Organisation. National Cancer Control Programmes. Policies and Managerial Guidelines. 2nd ed. WHO: Geneva; 2002.
16. Muir CS, Demaret E, Boyle P. The cancer registry in cancer control: an overview. The Role of the Registry in Cancer Control. IARC Scientific Publications: Lyon; 1985.
17. Armstrong BK. The role of the registry in cancer control. Cancer Causes Control 1992; 569:579-3.
18. Porta M. A dictionary of epidemiology. Oxford university press; 2014.
19. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. European Journal of Cancer 2009; 45(5):747-755.
20. Rothman KJ, Greenland S, Lash TL. (Eds.). Modern Epidemiology. Lippincott Williams & Wilkins; 2008.
21. Shields L, Twycross A. The difference between incidence and prevelance. Paediatric Nursing 2003; 15(7):50.
22. World Health Report. Changing History. WHO: Geneva; 2004.
23. World Health Organisation. Shaping the Future. WHO: Geneva; 2003.
24. Parkin DM. The role of cancer registries in cancer control”, International Journal of Clinical Oncology 2008; 13(2):102-111.
25. Singh GK, Miller BA, Hankey BF, Edwards BK. Area socioeconomic variations in US cancer incidence, mortality, stage, treatment, and survival, 1975–1999. NCI Cancer Surveillance Monograph Series, number 4; 2003.
26. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. International Journal of Cancer 1975; 15:617-631.
27. Tucker TC, Durbin EB, McDowell JK, Huang B. Unlocking the potential of population-based cancer registries. Cancer 2019; 125(21):3729-3737.
28. Sankila R, Démaret E, Hakama M, Lynge E, Schouten LJ, Parkin DM. (eds). Evaluation and Monitoring of Screening Programmes. European Commission: Brussels-Luxembourg; 2001.
29. Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA. Representation of older patients in cancer treatment trials. Cancer 1994; 74:2208-2214.
30. Krimphove MJ, Cole AP, Fletcher SA, Harmouch SS, Berg S, Lipsitz SR, Sun M, Nabi J, Nguyen PL, Hu JC, Kibel AS, Choueiri TK, Kluth LA, Trinh Q. Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer. Prostate Cancer and Prostatic Diseases 2019; 22: 125-136.
31. Hakama M, Beral V, Cullen JW, Parkin DM. (1990). Evaluating effectiveness of primary prevention of cancer. In Evaluating Effectiveness of Primary Prevention of Cancer 1990; 206-206.
32. Jemal A, Cokkinides VE, Shafey O, Thun MJ. Lung cancer trends in young adults, an early indicator of progress in tobacco control (United States). Cancer Causes Control 2003; 14: 579–585.
33. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. New England Journal of Medicine 1997; 336(26): 1855-1859.
34. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. Journal of the National Cancer Institute 2003; 95(17): 1276-1299.
35. Parkin DM. Comparability and quality control in cancer registration. IARC Technical Report 1994;19: 18-19.
36. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population- based trends in cancer treatment. Journal of the National Cancer Institute 2005; 97(19): 1407-1427.
37. Chu KC, Tarone RE, Chow WH, Hankey BF, Ries LA. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J. Natl Cancer Inst 1994; 86: 997–1006.
38. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, et al. Recent trends in U. S. breast cancer incidence, survival, and mortality rates. J. Natl Cancer Inst 1996; 88: 1571–1579.
39. Stockton D, Davies T, Day N, McCann J. Retrospective study of reasons for improved survival in patients with breast cancer in east Anglia, earlier diagnosis or better treatment BMJ 1997; 314: 472–475.
40. Allgood PC, Warwick J, Warren RML, Day NE, Duffy SW. A Case–Control Study of The Impact of the East Anglian Breast Screening Programme on Breast Cancer Mortality. British Journal of Cancer. 2008; 98(1): 206-209.